This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Ghrelin and hexarelin exhibit growth hormone-independent cardiovascular activities and protect pancreatic beta cells by enhancing insulin secretion and promoting beta cell regeneration. Hexarelin also regulates PPAR-γ, influencing lipid metabolism and insulin sensitivity, indicating potential therapeutic roles in diabetes and diabetic cardiomyopathy.
Why it matters
Understanding how ghrelin and hexarelin affect insulin production and heart function could lead to new treatments for diabetes and its cardiovascular complications.
How the study worked
This study is a literature review summarizing findings from multiple experimental studies on ghrelin and hexarelin's physiological roles and therapeutic potential in diabetes and associated heart diseases.
What this study cannot tell us
The review is based on preclinical and animal studies, with limited direct clinical evidence; the exact mechanisms and efficacy in humans remain to be fully established.
Read the original research
Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.
Endocrine, 49(2), 307-23
Citation
Mosa, Rasha Mofeed Habeeb; Zhang, Zhen; Shao, Renfu; Deng, Chao; Chen, Jiezhong; Chen, Chen. (2015). Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.. Endocrine, 49(2), 307-23. https://doi.org/10.1007/s12020-015-0531-z